NCT06482073View on ClinicalTrials.gov

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Lung CarcinomaMetastatic Malignant Neoplasm in the Lung
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06482073 - Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer) | Biotech Hunter | Biotech Hunter